U.S. urged to include Black, Latino communities in COVID-19 vaccine trials
By Julie Steenhuysen CHICAGO (Reuters) - A group of physicians and scientists are urging the U.S. government to include Black, Latino and indigenous Americans in the design and implementation of COVID-19 vaccine trials in hopes of building trust among these at-risk populations.
COVID-19 vaccine trials" src="https://images.firstpost.com/wp-content/uploads/reuters/07-2020/18/2020-07-17T165119Z_1_LYNXNPEG6G1DP_RTROPTP_2_HEALTH-CORONAVIRUS-VACCINE.jpg" alt="US urged to include Black Latino communities in COVID19 vaccine trials" width="300" height="225" />
By Julie Steenhuysen
CHICAGO (Reuters) - A group of physicians and scientists are urging the U.S. government to include Black, Latino and indigenous Americans in the design and implementation of COVID-19 vaccine trials in hopes of building trust among these at-risk populations.
Without such actions, populations most in need of the vaccine may be reluctant to take it, Dr. Richard Baron, chief executive of the American Board of Internal Medicine(ABIM) and colleagues, said in an open letter seen by Reuters to the head of Operation Warp Speed, the White House program set up to accelerate coronavirus vaccine development.
Baron is president of the ABIM Foundation which backed the successful "Choosing Wisely" campaign to reduce the overuse of unnecessary tests.
"We believe that it is entirely predictable that many Americans - especially Black, Latinx and indigenous people - will not take a vaccine, however safe and scientifically proven it may be, if they do not have trust in the process and people that produced it," according to the letter sent on Thursday.
According to a Reuters/Ipsos poll in May, only half of Black Americans, who represent a disproportionate percentage of coronavirus deaths, said they were somewhat or very interested in taking a vaccine, perhaps reflecting memories of an infamous U.S. government study that left black men deliberately untreated for syphilis.
To build trust, Baron said government researchers need to include community and faith leaders to help shape everything from vaccine development, distribution to communications strategies and make those visible publicly.
Warp Speed officials did not immediately respond to a request for comment.
Col. Nelson Michael, director of the U.S. Army’s Center for Infectious Disease Research, told Reuters in June that the Warp Speed team was looking into ways to engage community leaders, noting that Black Americans have "warranted skepticism about medicine and particularly the military, so Operation Warp Speed is not going to be an easy sell."
(Reporting by Julie Steenhuysen; editing by Diane Craft)
This story has not been edited by Firstpost staff and is generated by auto-feed.
By Eileen Soreng (Reuters) - Palladium prices hit a record on Tuesday, spurred by persistent supply worries, while gold held a narrow range as investors awaited policy signals from the U.S. Federal Reserve's meeting this week. Palladium hit a record of $2,962.50 per ounce earlier and was up 0.8% at $2,948.69 per ounce by 1:02 p.m
By Rajesh Kumar Singh and Ankit Ajmera (Reuters) -General Electric's cash outflow was smaller than estimated in the first quarter even as its lucrative jet-engine business struggled with the pandemic-led collapse of air travel, driving down company revenue. The company also reaffirmed its full-year free cash flow and earnings per share outlook
By Devika Krishna Kumar NEW YORK (Reuters) - Oil prices edged higher on Tuesday as OPEC+ was expected to stick to existing plans to boost oil output slightly from May 1, suggesting it does not see a lasting impact on demand from India's coronavirus crisis. The group has also ditched plans to hold a full ministerial meeting on Wednesday, sources said. A technical meeting on Monday had voiced concern about surging COVID-19 cases but kept its oil demand forecast unchanged.